Ignite Creation Date:
2025-12-24 @ 11:58 AM
Ignite Modification Date:
2026-01-31 @ 12:19 AM
Study NCT ID:
NCT04380961
Status:
COMPLETED
Last Update Posted:
2022-06-21
First Post:
2020-05-07
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study to Evaluate the Efficacy and Safety of Sirukumab in Confirmed Severe or Critical Confirmed Coronavirus Disease (COVID)-19
Sponsor:
Janssen Pharmaceutica N.V., Belgium
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
CR108820
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None